Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krissie Lenting

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Acta Neuropathologica|January 12, 2017
Glioma: experimental models and realityKrissie Lenting, Roel Verhaak, Mark Ter Laan, et al.
Oncotarget|May 4, 2017
In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated gliomaMohammed Khurshed, Remco J Molenaar, Krissie Lenting, et al.
ACS Chemical Neuroscience|March 16, 2019
Imaging Hyperpolarized Pyruvate and Lactate after Blood-Brain Barrier Disruption with Focused UltrasoundTom H Peeters, Thiele Kobus, Vincent Breukels, et al.
Acta Neuropathologica Communications|November 22, 2019
Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencingKrissie Lenting, Corina N A M van den Heuvel, Anne van Ewijk, et al.
Cancer & Metabolism|May 30, 2019
<i>Isocitrate dehydrogenase 1</i>-mutated cancers are sensitive to the green tea polyphenol epigallocatechin-3-gallateTom H Peeters, Krissie Lenting, Vincent Breukels, et al.
Scientific Reports|July 28, 2016
Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytomaSanne A M van Lith, Anna C Navis, Krissie Lenting, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2018
Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stressKrissie Lenting, Mohammed Khurshed, Tom H Peeters, et al.
Cancer Research|September 13, 2015
Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198Remco J Molenaar, Dennis Botman, Myrthe A Smits, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Acta Neuropathologica|January 12, 2017
Glioma: experimental models and realityKrissie Lenting, Roel Verhaak, Mark Ter Laan, et al.
Oncotarget|May 4, 2017
In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated gliomaMohammed Khurshed, Remco J Molenaar, Krissie Lenting, et al.
ACS Chemical Neuroscience|March 16, 2019
Imaging Hyperpolarized Pyruvate and Lactate after Blood-Brain Barrier Disruption with Focused UltrasoundTom H Peeters, Thiele Kobus, Vincent Breukels, et al.
Acta Neuropathologica Communications|November 22, 2019
Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencingKrissie Lenting, Corina N A M van den Heuvel, Anne van Ewijk, et al.
Cancer & Metabolism|May 30, 2019
<i>Isocitrate dehydrogenase 1</i>-mutated cancers are sensitive to the green tea polyphenol epigallocatechin-3-gallateTom H Peeters, Krissie Lenting, Vincent Breukels, et al.
Scientific Reports|July 28, 2016
Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytomaSanne A M van Lith, Anna C Navis, Krissie Lenting, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2018
Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stressKrissie Lenting, Mohammed Khurshed, Tom H Peeters, et al.
Cancer Research|September 13, 2015
Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198Remco J Molenaar, Dennis Botman, Myrthe A Smits, et al.
Pageof 1